Prolight Diagnostics AB (publ) (NGM:PRLD)

Market Cap	217.77M +24.1%
Revenue (ttm)	33.28M +32.2%
Net Income	-35.57M
EPS	-3.25
Shares Out	12.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,208
Average Volume	13,247
Open	n/a
Previous Close	18.58
Day's Range	n/a
52-Week Range	17.00 - 80.92
Beta	3.19
RSI	43.84
Earnings Date	Feb 25, 2026

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing systems in Sweden. The company offers Psyros, for measurement of biomarkers at extremely low concentrations; and MicroFlex, a point of care system to test with a small disposable cartridge. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 21
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2024, Prolight Diagnostics AB's revenue was 36.33 million, an increase of 50.02% compared to the previous year's 24.22 million. Losses were -26.94 million, -80.11% less than in 2023.